InvestorsHub Logo

hoffmann6383

06/10/22 9:17 AM

#485237 RE: HappyLibrarian #485219

Maybe that sounds out there...



I agree with this part.

have a good one hl!

CrashOverride

06/10/22 9:50 AM

#485257 RE: HappyLibrarian #485219

While the firm was not speaking with you they managed to deliver the first successful PIII Glioblastoma trial for nGBM and rGBM.

While the firm was not speaking with you they purchased Flaskworks, got MHRA GMP approval, and scaled up their single plant to 12,000 patient per year capacity.

While the firm was not speaking with you they got hundreds of patents filed and approved in countries across the globe.

While the firm was not speaking with you I picked up hundreds of thousands of shares as have many other family offices that have millions of their own money behind NWBO.

Correlation isn't causation but I think we have identified a trend that's beneficial for GBM patients and shareholders.

bas2020

06/10/22 10:18 AM

#485267 RE: HappyLibrarian #485219

no manipulation is needed to explain the low share price.


The pump up to $2 then the dump down to .38, was all orchestrated by the collusive AF cabal, who provided the false cover of "failed trial". It's as plain as day and is what they've done numerous times to numerous small biotechs.

Have no doubt that official TLD, journal and media coverage will follow soon to correct this manipulation.

biosectinvestor

06/11/22 3:26 AM

#485530 RE: HappyLibrarian #485219

Your description of this company is nothing like what I see. Amazing that some can see a glass 3/4ths full, waiting for that last but to happen and another can see it 9/10ths empty.